SC 13G

Company

BridgeBio Pharma, Inc.

Filed

July 11, 2019

Accession Number

0001193125-19-192463

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →